
Microprofit Biotech, a leading IVD manufacturer and global POCT supplier, successfully concluded its participation in MEDICA 2025, the world’s premier exhibition for the medical and in vitro diagnostics (IVD) industry. The event provided an important platform for international IVD distributors, medical device importers, and OEM/ODM partners seeking reliable diagnostic solutions.
During the four-day exhibition in Düsseldorf, our booth attracted numerous global IVD distributors, rapid test wholesalers, private label partners, and healthcare professionals. We sincerely thank both new and long-standing clients for engaging in in-depth discussions on market expansion, regional distribution opportunities, and long-term strategic cooperation.
At MEDICA 2025, Microprofit showcased its advanced portfolio as a professional rapid test manufacturer and fluorescence immunoassay analyzer supplier, including:
Rapid Diagnostic Test Kits (RDTs)
POCT Fluorescence Immunoassay (FIA) Analyzers
Fluorescence Immunoassay (FIA) Test Kits
Integrated Point-of-Care Testing (POCT) solutions
Customized OEM/ODM IVD solutions
Our products are widely used in hospitals, clinical laboratories, primary healthcare centers, and international distribution markets. As an experienced in vitro diagnostics company, Microprofit is committed to delivering accurate, efficient, and scalable diagnostic technologies to global healthcare systems.
A key highlight of the exhibition was fluorecare®, the proprietary diagnostic brand of Microprofit Biotech.
fluorecare® represents our advanced rapid diagnostic and fluorescence immunoassay technology platform, designed to support global IVD distributors and medical device partners with reliable, high-performance POCT solutions.
As a trusted IVD supplier, rapid test manufacturer, and OEM/ODM medical device partner, Microprofit continues to expand its worldwide distribution network and strengthen cooperation with international IVD distributors and healthcare partners.
We sincerely appreciate the trust and support of our global partners and look forward to building stronger collaborations in the global diagnostics market.
